Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA

References

• Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96
   PubMed Web of Science ®Google Scholar
• Hootman JBJ, Helmick C, Langmaid G. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation – United States, 2003–2005. MMWR Morb Mortal Wkly Rep 2006;55:1089-92
   PubMedGoogle Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
   PubMed Web of Science ®Google Scholar
• Conaghan PG, Dickson J, Grant RL. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 2008;336:502-3
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995;38:1541-6
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 1995;38:1535-40
   PubMed Web of Science ®Google Scholar
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007;15:981-1000
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration F. FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely. 2009. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149573.htm [Last accessed 11 November 2009]
   Google Scholar
• Roumie CL, Choma NN, Kaltenbach L, et al. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events – stroke, acute myocardial infarction, and death from coronary heart disease. Pharmacoepidemiol Drug Saf 2009;18:1053-63
   PubMed Web of Science ®Google Scholar
• Burnett BP, Levy R, Cole BJ. Metabolic mechanisms in the pathogenesis of osteoarthritis. A review. J Knee Surg 2006;19:191-7
   PubMedGoogle Scholar
• Altavilla D, Squadrito F, Bitto A, et al. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol 2009;157:1410-18
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration F. Medical Foods. 2009. Available at: http://www.fda.gov/Food/FoodSafety/Product-SpecificInformation/MedicalFoods/default.htm
   Google Scholar
• Morgan SL, Baggott JE. Medical foods: products for the management of chronic diseases. Nutr Rev 2006;64:495-501
   PubMed Web of Science ®Google Scholar
• Burnett BP, Jia Q, Zhao Y, et al. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food 2007;10:442-51
   PubMed Web of Science ®Google Scholar
• Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation 2005;112:759-70
   PubMed Web of Science ®Google Scholar
• Carmichael J, Shankel SW. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985;78:992-1000
   PubMed Web of Science ®Google Scholar
• Marcouiller P, Pelletier JP, Guevremont M, et al. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis. J Rheumatol 2005;32:704-12
   PubMed Web of Science ®Google Scholar
• Hudson N, Balsitis M, Everitt S, et al. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:742-7
   PubMed Web of Science ®Google Scholar
• Levy RM, Saikovsky R, Shmidt E, et al. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. Nutr Res 2009;29:298-304
   PubMed Web of Science ®Google Scholar
• Levy RM, Khokhlov A, Kopenkin S, et al. Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Advances in Therapy (in review), 2010
   Google Scholar
• Pillai L, Burnett BP, Levy RM. GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin. Curr Med Res Opin 2010;26:1055-63
   PubMed Web of Science ®Google Scholar
• Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80
   PubMed Web of Science ®Google Scholar
• Bartholow M. Top 200 Prescription Drugs of 2009. Pharmacy Times May 11, 2010. Available at: http://www.pharmacytimes.com/issue/pharmacy/2010/May2010/RxFocusTopDrugs-0510
   Google Scholar
• Talley NJ. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 2005;129:1753-5
   PubMed Web of Science ®Google Scholar
• Spiegel BM, Chiou CF, Ofman JJ. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis Rheum 2005;53:185-97
   PubMed Web of Science ®Google Scholar
• Unknown. Clinical Pharmacology: Dosing for omeprazole in H. Pylori. Gold Standard, An Elsevier Company 2010. Available at http://www.clinicalpharmacology.com/?epm=2_1 [Last accessed 27 July 2010]
   Google Scholar